MAM
Carat India appoints Megha Jain as VP – planning, South
Mumbai: Carat India, the media agency from the house of dentsu India has appointed Megha Jain as vice president – planning, South. She will report to Carat India CEO Anita Kotwani.
As per the mandate, Jain will focus on new business development and growth for Carat across the Southern market including Bengaluru and Kochi, while overseeing the agency’s existing clients, said the statement.
In her previous roles, Jain has driven effective brand building through strong media strategies and communications for FMCG brands like Colgate Palmolive, Unilever, Johnson & Johnson and Amul (GCMMF), to name a few. With over 15 years of experience in the media industry, she has led integrated media planning and strategic thinking, focusing on digital transformation for clients and their businesses. She has also been instrumental in spearheading communication planning for clients.
“The game plan for Carat India is to bring in leaders with an integrated skill set that can enhance client relationships,” said Anita Kotwani, commenting on the appointment. “Megha’s focus will be to drive strategic stewardship with our key clients in Bengaluru and other Southern markets. She will also be instrumental in helping us drive growth for the Southern market. Enriched with experience to work with top brands, she will add huge value to our global and local clients. I am thrilled that Megha will be part of the talented team and I believe she will be an asset to the organisation.”
Megha Jain added, “I am extremely excited to join the Carat family. It is a great opportunity to work with a diverse portfolio steaming from data, technology and healthcare across global and local markets. I look forward to collaborating with partner agencies across the dentsu network, drive growth under Anita’s leadership and working with some of the best minds in the country.”
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
